Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sean Bohen
Marketing
AZ, Merck's Lynparza scores data worth a shot at $1B boost
AstraZeneca and Merck are eyeing a $1 billion boost for Lynparza, thanks to a trial win for women who have just been diagnosed with ovarian cancer.
Tracy Staton
Jun 27, 2018 10:08am
AstraZeneca revs up for quick FDA review on new Lynparza use
Mar 28, 2017 10:55am
AZ's Lynparza fends off ovarian cancer
Mar 14, 2017 3:33pm